These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 2138049

  • 1. Cilazapril inhibits vascular responses to baroreflex-stimulated sympathetic neural activity in hypertensive patients.
    Fernandez PG, Bolli P, Lee C, Vasdev S.
    Can J Cardiol; 1990; 6(1):9-14. PubMed ID: 2138049
    [Abstract] [Full Text] [Related]

  • 2. Converting enzyme inhibition attenuates the noradrenaline response to the Valsalva maneuvre.
    Fernandez PG, Snedden W.
    Can J Cardiol; 1991 Jun; 7(5):214-22. PubMed ID: 1860093
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
    Fernandez PG, Bolli P, Lee C.
    Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
    [Abstract] [Full Text] [Related]

  • 5. Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapy.
    Lacourcière Y, Leenen F, Rangno R, Spence JD, Lenis JH, Myers MG.
    Can J Cardiol; 1994 Mar; 10(6):605-10. PubMed ID: 8044721
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
    Sánchez RA, Traballi CA, Barclay CA, Gilbert HB, Muscará M, Giannone C, Moledo LI.
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
    [Abstract] [Full Text] [Related]

  • 7. Changes in baroreflex sensitivity induced by cilazapril do not manifest in Valsalva and tachycardia ratios in hypertensives.
    Hasegawa J, Mori A, Yamamoto R, Tsuboi M, Kinugawa T.
    J Med; 1996 Feb; 27(1-2):89-96. PubMed ID: 8863180
    [No Abstract] [Full Text] [Related]

  • 8. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
    Fasanella d'Amore T, Bussien JP, Nussberger J, Waeber B, Turini GA, Brunner HR, Kler L, Francis RJ.
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
    Breithaupt K, Belz GG, Spielmanns DG, Neis W, Kirchner P.
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
    [Abstract] [Full Text] [Related]

  • 10. Alpha-adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin-converting enzyme inhibitor.
    Rosendorff C, Patton J, Radford HM, Kalliatakis B.
    J Cardiovasc Pharmacol; 1992 Feb; 19 Suppl 6():S105-9. PubMed ID: 1382157
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
    Derman WE, Sims R, Noakes TD.
    J Cardiovasc Pharmacol; 1992 Feb; 19 Suppl 5():S122-7. PubMed ID: 1381788
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
    Nussberger J, Fasanella d'Amore T, Porchet M, Waeber B, Brunner DB, Brunner HR, Kler L, Brown AN, Francis RJ.
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):39-44. PubMed ID: 2434792
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The influence of cilazapril on indices of autonomic function in normotensives and hypertensives.
    Elliott HL, Ajayi AA, Reid JL.
    Br J Clin Pharmacol; 1989 Jan; 27 Suppl 2(Suppl 2):303S-307S. PubMed ID: 2527543
    [Abstract] [Full Text] [Related]

  • 19. The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure.
    White WB, McCabe EJ, Hager WD, Schulman P.
    Clin Pharmacol Ther; 1988 Aug; 44(2):173-8. PubMed ID: 2969315
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.